Induced Adult Refractory Active Crohn's Disease Clinical Relieving by Using Thalidomide

NCT02956538 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Crohn Disease

Interventions

DRUG: Thalidomide
DRUG: placebo(for thalidomide)

Sponsor

Sixth Affiliated Hospital, Sun Yat-sen University